772 results on '"Thota, Prashanthi N."'
Search Results
2. Neoplastic Progression Risk in Females With Barrett’s Esophagus: A Systematic Review and Meta-Analysis of Individual Patient Data
3. Impact of the coronavirus disease 2019 pandemic on trends and healthcare disparities in use of screening colonoscopy and adenoma detection rates
4. Efficacy of peroral endoscopic myotomy for the treatment of functional esophagogastric junction outflow obstruction
5. A Tissue Systems Pathology Test Outperforms the Standard of Care Variables in Predicting Progression in Patients with Barrett’s Esophagus
6. Prediction of neoplastic progression in Barrett’s esophagus using nanoscale nuclear architecture mapping: a pilot study
7. Multicenter, Prospective Trial of Nonendoscopic Biomarker-Driven Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
8. Wide-area transepithelial sampling for dysplasia detection in Barrett’s esophagus: a systematic review and meta-analysis
9. Age of diagnosis in familial Barrett’s associated neoplasia
10. Peroral endoscopic myotomy is equally safe and highly effective treatment option in achalasia patients with both lower and higher ASA classification status
11. Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett’s Esophagus
12. Allaying uncertainty in diagnosing buried Barrett's esophagus
13. Clinical Success and Correlation of Eckardt Scores with Barium Esophagram After Peroral Endoscopic Myotomy in Achalasia
14. Peroral endoscopic myotomy is highly effective for achalasia patients with recurrent symptoms after pneumatic dilatation
15. Changes in esophageal physiology after paraesophageal hernia repair and Collis gastroplasty
16. Peroral Pyloromytomy is Effective and Safe for Postsurgical Gastroparesis
17. Trends and risk factors for 30-day readmissions in patients with acute cholangitis: analysis from the national readmission database
18. Proposal of high-risk adenoma detection rate as an impactful, complementary quality indicator of colonoscopy
19. Peroral Endoscopic Myotomy Is Effective for Patients With Achalasia and Normal Lower-Esophageal Sphincter Relaxation Pressures
20. Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma
21. Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett’s Esophagus to Esophageal Adenocarcinoma
22. Reintervention After Heller Myotomy for Achalasia: Is It Inevitable?
23. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
24. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study
25. S1312 Predictors of Complications After Heller Myotomy and Peroral Endoscopic Myotomy in Achalasia
26. S549 Is Hypothyroidism Associated With Esophageal Cancer? A Brief Review Utilizing the NIS Database
27. S494 Examining Characteristics of Eosinophilic Esophagitis Patients Presenting to the Hospital With COVID-19
28. S581 Patients of Achalasia Are at Increased Risk of Various Cancers: A National Database Study
29. S582 Need for Reinterventions After Per Oral Endoscopic Myotomy in Achalasia
30. S1314 Comparative Analysis of Patients with Achalasia Undergoing POEM and HM: Predictors of Readmission
31. S548 Suspected Barrett’s Esophagus: But No Intestinal Metaplasia - What to Do Next?
32. S1313 Predictors of Mortality After Heller Myotomy and Peroral Endoscopic Myotomy in Achalasia
33. S1854 Temporal Trends in the Risk of New-Onset Gastroparesis Following SARS-CoV-2 Infection: A Propensity Matched Cohort Study
34. S1855 The Epidemiology of Gastric Neuroendocrine Tumors in the United States: A Population-Based Study
35. S486 Higher Prevalence of Allergic Comorbidities in Children With Eosinophilic Esophagitis Compared to Adults in the United States: A Population-Based Study
36. S599 The Tissue Systems Pathology Test Predicts Risk of Progression in Medicare-Eligible Patients with Barrett’s Esophagus
37. Ablation Techniques for Barrett’s Esophagus and Dysplasia
38. Value of routine timed barium esophagram follow-up in achalasia after myotomy
39. Pancreatitis due to Clomiphene Citrate-Induced Hypertriglyceridemia: A Case Report and Literature Review
40. Peroral endoscopic myotomy leads to higher rates of abnormal esophageal acid exposure than laparoscopic Heller myotomy in achalasia
41. Correction to: Trends and risk factors for 30‑day readmissions in patients with acute cholangitis: analysis from the national readmission database
42. Impact of COVID-19 pandemic on trends and healthcare disparities in utilization of screening colonoscopy and adenoma detection rates
43. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy
44. Quality of Colonoscopy: A Comparison Between Gastroenterologists and Nongastroenterologists
45. Clinical Outcomes Based on the Timing of Appearance of Visible Lesions in Barrett’s Esophagus During Endoscopic Eradication Therapy
46. Obesity Does Not Impact Outcomes or Rates of Gastroesophageal Reflux After Peroral Endoscopic Myotomy in Achalasia
47. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett’s Esophagus with Dysplasia or Intramucosal Cancer
48. Temporal trends in utilization and outcomes of endoscopic retrograde cholangiopancreatography in acute cholangitis due to choledocholithiasis from 1998 to 2012
49. Endoscopic Treatments of GERD
50. Post-ablation lymphocytic esophagitis in Barrett esophagus with high grade dysplasia or intramucosal carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.